SEC Form 4 · accession 0001201252-26-000010
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Victor J Dzau
Director
Period of report
Jul 22, 2026
Accepted (ET)
Jul 23, 2026 · 4:48 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001082554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F1,F3 | $0.00 | Jul 22, 2026 | A | 730 | A | Jul 22, 2027 | — | Common Stock | 730 | 730 | D |
| Stock OptionF2 | $527.07 | Jul 22, 2026 | A | 2,300 | A | Jul 22, 2027 | Jul 22, 2033 | Common Stock | 2,300 | 2,300 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- F2In connection with Dr. Dzau's appointment to the Board of Directors on July 22, 2026, he was awarded restricted stock units and stock options in accordance with the Non-Employee Director Compensation Program, as follows: (a) 380 restricted stock units and 1,190 stock options, representing his initial grant upon joining the Board, and (b) 350 restricted stock units and 1,110 stock options, which are pro-rata grants representing the remainder of the 2026-2027 Board service year. Each award becomes fully vests on the one-year anniversary of the grant date.
- F3Not applicable as restricted stock units do not have an expiration date.